Document:

EXHIBIT 10.16

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PREFERRED STOCKHOLDERS AGREEMENT

 

 

 

NEUROTROPE, INC.

 

 

August 23, 2013

 

 

 

 

 

 

 

 

 

 

 

 

    	 

    	 

    

 

 

TABLE OF CONTENTS

 

	1.	Definitions	1
	2.	Registration Rights	 
	 	2.1	Demand Registration	4
	 	2.2	Company Registration	5
	 	2.3	Underwriting Requirements	6
	 	2.4	Obligations of the Company	6
	 	2.5	Furnish Information	8
	 	2.6	Expenses of Registration	9
	 	2.7	Delay of Registration	9
	 	2.8	Indemnification	10
	 	2.9	Reports Under Exchange Act	10
	 	2.10	Limitations on Subsequent Registration Rights	12
	 	2.11	Transfer of Registration Rights	12
	 	2.12	Restrictions on Transfer	13
	 	2.13	Termination of Registration Rights	14
	 	2.14	Aggregation of Stock	15
	3.	Voting Provisions	15
	 	3.1	Vote to Increase Authorized Common Stock	15
	 	3.2	Restrictions on Sales of Control of the Company	15
	4.	Agreement Among the Company and the Stockholders	15
	 	4.1	Right of First Refusal	15
	 	4.2	Effect of Failure to Comply	17
	 	4.3	Exempt Transfers	17
	 	4.4	Prohibited Transfers	18
	 	4.5	Termination of Transfer Rights and Restrictions	18
	5.	Legends	18
	6.	Lock-Up	19
	 	6.1	Agreement to Lock-Up	19
	 	6.2	Stop Transfer Instructions	19
	7.	Additional Covenants	19
	 	7.1	Insurance	19

 

    	i

    	 

    

 

 

TABLE OF CONTENTS

 

	8.	Miscellaneous	20
	 	8.1	Transfers	20
	 	8.2	Successors and Assigns	20
	 	8.3	Governing Law	20
	 	8.4	Counterparts	20
	 	8.5	Titles and Subtitles	20
	 	8.6	Notices	20
	 	8.7	Amendments and Waivers	21
	 	8.8	Severability	21
	 	8.9	Aggregation of Stock	21
	 	8.10	Additional Stockholders	21
	 	8.11	Entire Agreement	21
	 	8.12	Dispute Resolution	21
	 	8.13	Delays or Omissions	21
	 	 	 	 

 

 

 

Schedule A-Schedule of Stockholders

 

 

 

 

 

 

 

 

    	ii

    	 

    

 

 

PREFERRED STOCKHOLDERS AGREEMENT

 

THIS PREFERRED STOCKHOLDERS
AGREEMENT (the “Agreement”) is made as of the 23rd day of August, 2013, by and among Neurotrope, Inc., a Nevada
corporation (the “Company”), each of the stockholders listed on Schedule A hereto, each of which is
referred to in this Agreement as a “Stockholder,” and any additional Person that becomes a party to this Agreement
in accordance with the terms hereof.

 

RECITALS

 

WHEREAS, the
Stockholders are holders of Series A Preferred Stock of the Company.

 

WHEREAS, the
Series A Preferred Stock of the Company held by the Stockholders was issued pursuant to the terms of the Merger Agreement, dated
as of the date hereof, by and among Neurotrope Acquisition, Inc., a Delaware corporation and a wholly owned subsidiary of the
Company, and Neurotrope BioScience, Inc., a Delaware corporation (“Neurotrope”, and such agreement, the “Merger
Agreement”), pursuant to which Neurotrope Acquisition, Inc. merged with and into Neurotrope, with Neurotrope as the
surviving corporation, and each outstanding share of Series A Preferred Stock of Neurotrope was converted into one share of Series
A Preferred Stock of the Company (the “Merger”).

 

WHEREAS, certain
of the Stockholders were parties to the Investor Rights Agreement, Voting Agreement and Investor Rights Agreement, each dated
February 28, 2013, between the Company and certain of its stockholders (the “Prior Agreements”).

 

WHEREAS, in connection
with the Merger, the Stockholders wish to terminate the Prior Agreements and enter into this Agreement, which shall provide for
certain rights and obligations of the Stockholders as set forth in this Agreement;

 

NOW, THEREFORE,
the parties hereby agree as follows:

 

1.Definitions.
For purposes of this Agreement:

 

1.1“Affiliate”
means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under
common control with such Person, including without limitation any general partner, managing member, officer or director of such
Person or any venture capital fund now or hereafter existing that is controlled by one or more general partners or managing members
of, or shares the same management company with, such Person.

 

1.2“Capital
Stock” means (a) shares of Common Stock and Preferred Stock (whether now outstanding or hereafter issued in any context),
(b) shares of Common Stock issued or issuable upon conversion of Preferred Stock and (c) shares of Common Stock issued or issuable
upon exercise or conversion, as applicable, of stock options, warrants or other convertible securities of the Company, in each
case now owned or subsequently acquired by any Stockholder, or their respective successors or permitted transferees or assigns.
For purposes of the number of shares of Capital Stock held by a Stockholder (or any other calculation based thereon), all shares
of Preferred Stock shall be deemed to have been converted into Common Stock at the then-applicable conversion ratio.

 

    	 

    	 

    

1.3“Change
of Control” means a transaction or series of related transactions in which a person, or a group of related persons,
acquires from stockholders of the Company shares representing more than fifty percent (50%) of the outstanding voting power of
the Company.

 

1.4“Common
Stock” means shares of the Company’s common stock, par value $0.0001 per share.

 

1.5“Company
Notice” means written notice from the Company notifying the selling Stockholder that the Company intends to exercise
its Right of First Refusal as to some or all of the Transfer Stock with respect to any Proposed Transfer.

 

1.6“Damages”
means any loss, damage, claim or liability (joint or several) to which a party hereto may become subject under the Securities
Act, the Exchange Act, or other federal or state law, insofar as such loss, damage, claim or liability (or any action in respect
thereof) arises out of or is based upon (i) any untrue statement or alleged untrue statement of a material fact contained in any
registration statement of the Company, including any preliminary prospectus or final prospectus contained therein or any amendments
or supplements thereto; (ii) an omission or alleged omission to state therein a material fact required to be stated therein, or
necessary to make the statements therein not misleading; or (iii) any violation or alleged violation by the indemnifying party
(or any of its agents or Affiliates) of the Securities Act, the Exchange Act, any state securities law, or any rule or
regulation promulgated under the Securities Act, the Exchange Act, or any state securities law.

 

1.7“Derivative
Securities” means any securities or rights convertible into, or exercisable or exchangeable for (in each case, directly
or indirectly), Common Stock, including options and warrants.

 

1.8“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

1.9“Excluded
Registration” means (i) a registration relating to the sale of securities to employees of the Company or a subsidiary
pursuant to a stock option, stock purchase, or similar plan; (ii) a registration relating to an SEC Rule 145 transaction; (iii)
a registration on any form that does not include substantially the same information as would be required to be included in a registration
statement covering the sale of the Registrable Securities; or (iv) a registration in which the only Common Stock being registered
is Common Stock issuable upon conversion of debt securities that are also being registered.

 

1.10“Form
S-1” means such form under the Securities Act as in effect on the date hereof or any successor registration form under
the Securities Act subsequently adopted by the SEC.

 

    	2

    	 

    

1.11“Form
S-3” means such form under the Securities Act as in effect on the date hereof or any registration form under the Securities
Act subsequently adopted by the SEC that permits incorporation of substantial information by reference to other documents filed
by the Company with the SEC.

 

1.12“GAAP”
means generally accepted accounting principles in the United States.

 

1.13“Holder”
means any holder of Registrable Securities who is a party to this Agreement.

 

1.14“Immediate
Family Member” means a child, stepchild, grandchild, parent, stepparent, grandparent, spouse, domestic partner, sibling,
mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including adoptive
relationships, of a natural person referred to herein.

 

1.15“Initiating
Holders” means, collectively, Holders who properly initiate a registration request under this Agreement.

 

1.16“Person”
means any individual, corporation, partnership, trust, limited liability company, association or other entity.

 

1.17“Preferred
Stock” means collectively, all shares of Series A Preferred Stock.

 

1.18“Proposed
Transfer Notice” means written notice from a Stockholder setting forth the terms and conditions of a Proposed Transfer.

 

1.19“Proposed
Transfer” means any assignment, sale, offer to sell, pledge, mortgage, hypothecation, encumbrance, disposition of or
any other like transfer or encumbering of any Transfer Stock (or any interest therein) proposed by any of the Stockholders.

 

1.20“Prospective
Transferee” means any person to whom a Stockholder proposes to make a Proposed Transfer.

 

1.21“Qualified
Public Offering” means an underwritten public offering of equity securities of the Company with a price to the public
of at least $5 per share and aggregate gross proceeds of at least $30,000,000.

 

1.22“Registrable
Securities then outstanding” means the number of shares determined by adding the number of shares of outstanding Common
Stock that are Registrable Securities and the number of shares of Common Stock issuable (directly or indirectly) pursuant
to then exercisable and/or convertible securities that are Registrable Securities.

 

1.23“Registrable
Securities” means (i) the Common Stock issuable or issued upon conversion of the Series A Preferred Stock and
(ii) any Common Stock issued as (or issuable upon the conversion or exercise of any warrant, right, or other security that is
issued as) a dividend or other distribution with respect to, or in exchange for or in replacement of, the shares referenced in
clauses (i) and (ii) above; excluding in all cases, however, any Registrable Securities sold by a Person in a transaction
in which the applicable rights under this Agreement are not assigned pursuant to Subsection 2.12, and excluding for purposes
of Section ‎0 any shares for which registration rights have terminated
pursuant to Subsection ‎0 of this Agreement.

 

    	3

    	 

    

1.24“Restricted
Securities” means the securities of the Company required to bear the legend set forth in Subsection ‎0
hereof.

 

1.25“Right
of First Refusal” means the right, but not an obligation, of the Company, or its permitted transferees or assigns, to
purchase some or all of the Transfer Stock with respect to a Proposed Transfer, on the terms and conditions specified in the Proposed
Transfer Notice.

 

1.26“SEC
Rule 144” means Rule 144 promulgated by the SEC under the Securities Act.

 

1.27“SEC
Rule 145” means Rule 145 promulgated by the SEC under the Securities Act.

 

1.28“SEC”
means the Securities and Exchange Commission.

 

1.29“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

1.30“Selling
Expenses” means all underwriting discounts, selling commissions, and stock transfer taxes applicable to the sale of
Registrable Securities, and fees and disbursements of counsel for any Holder, except for the fees and disbursements of the Selling
Holder Counsel borne and paid by the Company as provided in Subsection ‎0.

 

1.31“Series
A Director” means any director of the Company that the holders of record of the Series A Preferred Stock
are entitled to elect pursuant to the Company’s Certificate of Incorporation.

 

1.32“Series
A Preferred Stock” means shares of the Company’s Series A Preferred Stock, par value $0.0001 per share.

 

1.33“Stockholder
Notice” means written notice from a Stockholder notifying the Company and the selling Stockholder that such Stockholder
intends to exercise its Secondary Refusal Right as to a portion of the Transfer Stock with respect to any Proposed Transfer.

 

1.34“Transfer
Stock” means shares of Capital Stock owned by a Stockholder, or issued to a Stockholder after the date hereof (including,
without limitation, in connection with any stock split, stock dividend, recapitalization, reorganization, or the like).

 

    	4

    	 

    

2.Registration
Rights. The Company covenants and agrees as follows:

 

2.1Demand
Registration.

 

(a)Form S-1
Demand. If at any time after the earlier of (i) five (5) years after the date of this Agreement or (ii) one hundred eighty
(180) days after the effective date of the registration statement for a Qualified Public Offering, the Company receives a request
from Holders of forty percent (40%) of the Registrable Securities then outstanding that the Company file a Form S-1 registration
statement with respect to Registrable Securities having an anticipated aggregate offering price, net of Selling Expenses,
of at least $15 million, then the Company shall (x) within ten (10) days after the date such request is given, give notice thereof
(the “Demand Notice”) to all Holders other than the Initiating Holders; and (y) as soon as practicable, and
in any event within sixty (60) days after the date such request is given by the Initiating Holders, file a Form S-1 registration
statement under the Securities Act covering all Registrable Securities that the Initiating Holders requested to be registered
and any additional Registrable Securities requested to be included in such registration by any other Holders, as specified by
notice given by each such Holder to the Company within twenty (20) days of the date the Demand Notice is given, and in each case,
subject to the limitations of Subsection 2.1‎0, Subsection 2.1‎0
and Subsection ‎0.

 

(b)Form S-3
Demand. If at any time when it is eligible to use a Form S-3 registration statement, the Company receives a request from Holders
of at least thirty percent (30%) of the Registrable Securities then outstanding that the Company file a Form S-3 registration
statement with respect to outstanding Registrable Securities of such Holders having an anticipated aggregate offering price, net
of Selling Expenses, of at least $1 million, then the Company shall (i) within ten (10) days after the date such request is given,
give a Demand Notice to all Holders other than the Initiating Holders; and (ii) as soon as practicable, and in any event within
forty-five (45) days after the date such request is given by the Initiating Holders, file a Form S-3 registration statement under
the Securities Act covering all Registrable Securities requested to be included in such registration by any other Holders, as
specified by notice given by each such Holder to the Company within twenty (20) days of the date the Demand Notice is given, and
in each case, subject to the limitations of Subsection 2.1‎0, Subsection 2.1(d)
and Subsection ‎0. 

 

(c)Notwithstanding
the foregoing obligations, if the Company furnishes to Holders requesting a registration pursuant to this Subsection ‎0
a certificate signed by the Company’s chief executive officer stating that in the good faith judgment of the Company’s
Board of Directors it would be materially detrimental to the Company and its stockholders for such registration statement to be
filed and it is therefore necessary to defer the filing of such registration statement, then the Company shall have the right
to defer taking action with respect to such filing, and any time periods with respect to filing or effectiveness thereof shall
be tolled correspondingly, for a period of not more than one hundred twenty (120) days after the request of the Initiating Holders
is given; provided, however, that the Company may not invoke this right more than once in any twelve (12) month
period; and provided further that the Company shall not register any securities for its own account or that of any
other stockholder during such one hundred twenty (120) day period other than an Excluded Registration.

 

    	5

    	 

    

(d)The Company
shall not be obligated to effect, or to take any action to effect, any registration pursuant to Subsection 2.1‎0:
(i) during the period that is sixty (60) days before the Company’s good faith estimate of the date of filing of, and ending
on a date that is one hundred eighty (180) days after the effective date of, a Company-initiated registration, provided,
that the Company is actively employing in good faith commercially reasonable efforts to cause such registration statement to become
effective; (ii) after the Company has effected two registrations pursuant to Subsection 2.1‎0;
or (iii) if the Initiating Holders propose to dispose of shares of Registrable Securities that may be immediately registered on
Form S-3 pursuant to a request made pursuant to Subsection 2.1‎0. The Company
shall not be obligated to effect, or to take any action to effect, any registration pursuant to Subsection 2.1‎0:
(i) during the period that is thirty (30) days before the Company’s good faith estimate of the date of filing of, and
ending on a date that is one hundred eighty (180) days after the effective date of, a prior registration, provided, that
the Company is actively employing in good faith commercially reasonable efforts to cause such registration statement to become
effective; or (ii) if the Company has effected two registrations pursuant to Subsection 2.1‎0
within the twelve (12) month period immediately preceding the date of such request. A registration shall not be counted as
“effected” for purposes of this Subsection 2.1‎0 until such time as
the applicable registration statement has been declared effective by the SEC, unless the Initiating Holders withdraw their request
for such registration, elect not to pay the registration expenses therefor, and forfeit their right to one demand registration
statement pursuant to Subsection ‎0, in which case such withdrawn registration
statement shall be counted as “effected” for purposes of this Subsection 2.1‎0.

 

2.2Company
Registration. If the Company proposes to register (including, for this purpose, a registration effected by the Company for
stockholders other than the Holders) any of its Common Stock under the Securities Act in connection with the public offering of
such securities solely for cash (other than in an Excluded Registration), the Company shall, at such time, promptly give each
Holder notice of such registration. Upon the request of each Holder given within twenty (20) days after such notice is given by
the Company, the Company shall, subject to the provisions of Subsection ‎0, cause
to be registered all of the Registrable Securities that each such Holder has requested to be included in such registration. The
Company shall have the right to terminate or withdraw any registration initiated by it under this Subsection ‎0
before the effective date of such registration, whether or not any Holder has elected to include Registrable Securities in such
registration. The expenses (other than Selling Expenses) of such withdrawn registration shall be borne by the Company in accordance
with Subsection ‎0.

 

2.3Underwriting
Requirements.

 

(a)If, pursuant
to Subsection ‎0, the Initiating Holders intend to distribute the Registrable
Securities covered by their request by means of an underwriting, they shall so advise the Company as a part of their request made
pursuant to Subsection ‎0, and the Company shall include such information in the
Demand Notice. The underwriter(s) will be selected by the Company and shall be reasonably acceptable to a majority in interest
of the Initiating Holders. In such event, the right of any Holder to include such Holder’s Registrable Securities in such
registration shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s
Registrable Securities in the underwriting to the extent provided herein. All Holders proposing to distribute their securities
through such underwriting shall (together with the Company as provided in Subsection ‎0)
enter into an underwriting agreement in customary form with the underwriter(s) selected for such underwriting. Notwithstanding
any other provision of this Subsection ‎0, if the underwriter(s) advise(s) the
Initiating Holders in writing that marketing factors require a limitation on the number of shares to be underwritten, then the
Initiating Holders shall so advise all Holders of Registrable Securities that otherwise would be underwritten pursuant hereto,
and the number of Registrable Securities that may be included in the underwriting shall be allocated among such Holders of Registrable
Securities, including the Initiating Holders, in proportion (as nearly as practicable) to the number of Registrable Securities
owned by each Holder or in such other proportion as shall mutually be agreed to by all such selling Holders; provided,
however, that the number of Registrable Securities held by the Holders to be included in such underwriting shall not be
reduced unless all other securities are first entirely excluded from the underwriting. To facilitate the allocation of shares
in accordance with the above provisions, the Company or the underwriters may round the number of shares allocated to any Holder
to the nearest 100 shares.

 

    	6

    	 

    

(b)In connection
with any offering involving an underwriting of shares of the Company’s capital stock pursuant to Subsection ‎0,
the Company shall not be required to include any of the Holders’ Registrable Securities in such underwriting unless the
Holders accept the terms of the underwriting as agreed upon between the Company and its underwriters, and then only in such quantity
as the underwriters in their sole discretion determine will not jeopardize the success of the offering by the Company. If the
total number of securities, including Registrable Securities, requested by stockholders to be included in such offering exceeds
the number of securities to be sold (other than by the Company) that the underwriters in their reasonable discretion determine
is compatible with the success of the offering, then the Company shall be required to include in the offering only that number
of such securities, including Registrable Securities, which the underwriters and the Company in their sole discretion determine
will not jeopardize the success of the offering. If the underwriters determine that less than all of the Registrable Securities
requested to be registered can be included in such offering, then the Registrable Securities that are included in such offering
shall be allocated among the selling Holders in proportion (as nearly as practicable to) the number of Registrable Securities
owned by each selling Holder or in such other proportions as shall mutually be agreed to by all such selling Holders. To facilitate
the allocation of shares in accordance with the above provisions, the Company or the underwriters may round the number of shares
allocated to any Holder to the nearest 100 shares. Notwithstanding the foregoing, in no event shall (i) the number of Registrable
Securities included in the offering be reduced unless all other securities (other than securities to be sold by the Company) are
first entirely excluded from the offering, or (ii) the number of Registrable Securities included in the offering be reduced below
thirty percent (30%) of the total number of securities included in such offering, unless such offering is a Qualified Public Offering,
in which case the selling Holders may be excluded further if the underwriters make the determination described above and no other
stockholder’s securities are included in such offering. For purposes of the provision in this Subsection 2.3‎0
concerning apportionment, for any selling Holder that is a partnership, limited liability company, or corporation, the partners,
members, retired partners, retired members, stockholders, and Affiliates of such Holder, or the estates and Immediate Family Members
of any such partners, retired partners, members, and retired members and any trusts for the benefit of any of the foregoing Persons,
shall be deemed to be a single “selling Holder,” and any pro rata reduction with respect to such “selling Holder”
shall be based upon the aggregate number of Registrable Securities owned by all Persons included in such “selling Holder,”
as defined in this sentence.

    	7

    	 

    

 

2.4Obligations
of the Company. Whenever required under this Section ‎0 to effect the registration
of any Registrable Securities, the Company shall, as expeditiously as reasonably possible:

 

(a)prepare and
file with the SEC a registration statement with respect to such Registrable Securities and use its commercially reasonable efforts
to cause such registration statement to become effective and, upon the request of the Holders of a majority of the Registrable
Securities registered thereunder, keep such registration statement effective for a period of up to one hundred twenty (120) days
or, if earlier, until the distribution contemplated in the registration statement has been completed; provided, however,
that (i) such one hundred twenty (120) day period shall be extended for a period of time equal to the period the Holder refrains,
at the request of an underwriter of Common Stock (or other securities) of the Company, from selling any securities included in
such registration, and (ii) in the case of any registration of Registrable Securities on Form S-3 that are intended to be offered
on a continuous or delayed basis, subject to compliance with applicable SEC rules, such one hundred twenty (120) day period shall
be extended for up to 60 days, if necessary, to keep the registration statement effective until all such Registrable Securities
are sold;

 

(b)prepare and
file with the SEC such amendments and supplements to such registration statement, and the prospectus used in connection with such
registration statement, as may be necessary to comply with the Securities Act in order to enable the disposition of all securities
covered by such registration statement;

 

(c)furnish to
the selling Holders such numbers of copies of a prospectus, including a preliminary prospectus, as required by the Securities
Act, and such other documents as the Holders may reasonably request in order to facilitate their disposition of their Registrable
Securities;

 

(d)use its commercially
reasonable efforts to register and qualify the securities covered by such registration statement under such other securities or
blue-sky laws of such jurisdictions as shall be reasonably requested by the selling Holders; provided that the Company
shall not be required to qualify to do business or to file a general consent to service of process in any such states or jurisdictions,
unless the Company is already subject to service in such jurisdiction and except as may be required by the Securities Act;

 

(e)in the event
of any underwritten public offering, enter into and perform its obligations under an underwriting agreement, in usual and customary
form, with the underwriter(s) of such offering;

 

(f)use its commercially
reasonable efforts to cause all such Registrable Securities covered by such registration statement to be listed on a national
securities exchange or trading system and each securities exchange and trading system (if any) on which similar securities issued
by the Company are then listed;

 

(g)provide a transfer
agent and registrar for all Registrable Securities registered pursuant to this Agreement and provide a CUSIP number for all such
Registrable Securities, in each case not later than the effective date of such registration;

 

    	8

    	 

    

(h)promptly make
available for inspection by the selling Holders, any underwriter(s) participating in any disposition pursuant to such registration
statement, and any attorney or accountant or other agent retained by any such underwriter or selected by the selling Holders,
all financial and other records, pertinent corporate documents, and properties of the Company, and cause the Company’s officers,
directors, employees, and independent accountants to supply all information reasonably requested by any such seller, underwriter,
attorney, accountant, or agent, in each case, as necessary or advisable to verify the accuracy of the information in such registration
statement and to conduct appropriate due diligence in connection therewith;

 

(i)notify each
selling Holder, promptly after the Company receives notice thereof, of the time when such registration statement has been declared
effective or a supplement to any prospectus forming a part of such registration statement has been filed; and

 

(j)after such
registration statement becomes effective, notify each selling Holder of any request by the SEC that the Company amend or supplement
such registration statement or prospectus.

 

In addition, the Company
shall ensure that, at all times after any registration statement covering a public offering of securities of the Company under
the Securities Act shall have become effective, its insider trading policy shall provide that the Company’s directors may
implement a trading program under Rule 10b5-1 of the Exchange Act.

 

2.5Furnish
Information. It shall be a condition precedent to the obligations of the Company to take any action pursuant to this Section
‎0 with respect to the Registrable Securities of any selling Holder that such Holder
shall furnish to the Company such information regarding itself, the Registrable Securities held by it, and the intended method
of disposition of such securities as is reasonably required to effect the registration of such Holder’s Registrable Securities.

 

2.6Expenses
of Registration. All expenses (other than Selling Expenses) incurred in connection with registrations, filings, or qualifications
pursuant to Section ‎0, including all registration, filing, and qualification
fees; printers’ and accounting fees; fees and disbursements of counsel for the Company; and the reasonable fees and disbursements,
not to exceed $50,000, of one counsel for the selling Holders (“Selling Holder Counsel”), shall be borne and paid
by the Company; provided, however, that the Company shall not be required to pay for any expenses of any registration
proceeding begun pursuant to Subsection ‎0 if the registration request is subsequently
withdrawn at the request of the Holders of a majority of the Registrable Securities to be registered (in which case all selling
Holders shall bear such expenses pro rata based upon the number of Registrable Securities that were to be included in the withdrawn
registration), unless the Holders of a majority of the Registrable Securities agree to forfeit their right to one registration
pursuant to Subsection ‎0 or Subsection ‎0,
as the case may be. All Selling Expenses relating to Registrable Securities registered pursuant to this Section ‎0
shall be borne and paid by the Holders pro rata on the basis of the number of Registrable Securities registered on their behalf.

 

    	9

    	 

    

2.7Delay
of Registration. No Holder shall have any right to obtain or seek an injunction restraining or otherwise delaying any registration
pursuant to this Agreement as the result of any controversy that might arise with respect to the interpretation or implementation
of this Section 2.

 

2.8Indemnification.
If any Registrable Securities are included in a registration statement under this Section ‎0:

 

(a)To the extent
permitted by law, the Company will indemnify and hold harmless each selling Holder, and the partners, members, officers, directors,
and stockholders of each such Holder; legal counsel and accountants for each such Holder; any underwriter (as defined in the Securities
Act) for each such Holder; and each Person, if any, who controls such Holder or underwriter within the meaning of the Securities
Act or the Exchange Act, against any Damages, and the Company will pay to each such Holder, underwriter, controlling Person, or
other aforementioned Person any legal or other expenses reasonably incurred thereby in connection with investigating or defending
any claim or proceeding from which Damages may result, as such expenses are incurred; provided, however, that the
indemnity agreement contained in this Subsection 2.8‎0 shall not apply to amounts
paid in settlement of any such claim or proceeding if such settlement is effected without the consent of the Company, which consent
shall not be unreasonably withheld, nor shall the Company be liable for any Damages to the extent that they arise out of or are
based upon actions or omissions made in reliance upon and in conformity with written information furnished by or on behalf of
any such Holder, underwriter, controlling Person, or other aforementioned Person expressly for use in connection with such registration.

 

(b)To the extent
permitted by law, each selling Holder, severally and not jointly, will indemnify and hold harmless the Company, and each of its
directors, each of its officers who has signed the registration statement, each Person (if any), who controls the Company within
the meaning of the Securities Act, legal counsel and accountants for the Company, any underwriter (as defined in the Securities
Act), any other Holder selling securities in such registration statement, and any controlling Person of any such underwriter or
other Holder, against any Damages, in each case only to the extent that such Damages arise out of or are based upon actions or
omissions made in reliance upon and in conformity with written information furnished by or on behalf of such selling Holder expressly
for use in connection with such registration; and each such selling Holder will pay to the Company and each other aforementioned
Person any legal or other expenses reasonably incurred thereby in connection with investigating or defending any claim or proceeding
from which Damages may result, as such expenses are incurred; provided, however, that the indemnity agreement contained
in this Subsection 2.8‎0 shall not apply to amounts paid in settlement of any
such claim or proceeding if such settlement is effected without the consent of the Holder, which consent shall not be unreasonably
withheld; and provided further that in no event shall the aggregate amounts payable by any Holder by way of indemnity
or contribution under Subsections 2.8‎0 and 2.8‎0
exceed the proceeds from the offering received by such Holder (net of any Selling Expenses paid by such Holder), except in
the case of fraud or willful misconduct by such Holder.

 

(c)Promptly after
receipt by an indemnified party under this Subsection ‎0 of notice of the
commencement of any action (including any governmental action) for which a party may be entitled to indemnification hereunder,
such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Subsection
‎0, give the indemnifying party notice of the commencement thereof. The indemnifying
party shall have the right to participate in such action and, to the extent the indemnifying party so desires, participate jointly
with any other indemnifying party to which notice has been given, and to assume the defense thereof with counsel mutually satisfactory
to the parties; provided, however, that an indemnified party (together with all other indemnified parties that may
be represented without conflict by one counsel) shall have the right to retain one separate counsel, with the fees and expenses
to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying
party would be inappropriate due to actual or potential differing interests between such indemnified party and any other party
represented by such counsel in such action. The failure to give notice to the indemnifying party within a reasonable time of the
commencement of any such action shall relieve such indemnifying party of any liability to the indemnified party under this Subsection
‎0, to the extent that such failure materially prejudices the indemnifying party’s
ability to defend such action. The failure to give notice to the indemnifying party will not relieve it of any liability that
it may have to any indemnified party otherwise than under this Subsection ‎0.

 

    	10

    	 

    

(d)To provide
for just and equitable contribution to joint liability under the Securities Act in any case in which either (i) any party otherwise
entitled to indemnification hereunder makes a claim for indemnification pursuant to this Subsection ‎0
but it is judicially determined (by the entry of a final judgment or decree by a court of competent jurisdiction and the expiration
of time to appeal or the denial of the last right of appeal) that such indemnification may not be enforced in such case, notwithstanding
the fact that this Subsection ‎0 provides for indemnification in such case, or
(ii) contribution under the Securities Act may be required on the part of any party hereto for which indemnification is provided
under this Subsection ‎0, then, and in each such case, such parties will contribute
to the aggregate losses, claims, damages, liabilities, or expenses to which they may be subject (after contribution from others)
in such proportion as is appropriate to reflect the relative fault of each of the indemnifying party and the indemnified party
in connection with the statements, omissions, or other actions that resulted in such loss, claim, damage, liability, or expense,
as well as to reflect any other relevant equitable considerations. The relative fault of the indemnifying party and of the indemnified
party shall be determined by reference to, among other things, whether the untrue or allegedly untrue statement of a material
fact, or the omission or alleged omission of a material fact, relates to information supplied by the indemnifying party or by
the indemnified party and the parties’ relative intent, knowledge, access to information, and opportunity to correct or
prevent such statement or omission; provided, however, that, in any such case, (x) no Holder will be required to
contribute any amount in excess of the public offering price of all such Registrable Securities offered and sold by such Holder
pursuant to such registration statement, and (y) no Person guilty of fraudulent misrepresentation (within the meaning of Section
11(f) of the Securities Act) will be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation;
and provided further that in no event shall a Holder’s liability pursuant to this Subsection 2.8‎0,
when combined with the amounts paid or payable by such Holder pursuant to Subsection 2.8‎0,
exceed the proceeds from the offering received by such Holder (net of any Selling Expenses paid by such Holder), except in the
case of willful misconduct or fraud by such Holder.

 

    	11

    	 

    

(e)Notwithstanding
the foregoing, to the extent that the provisions on indemnification and contribution contained in the underwriting agreement entered
into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the
underwriting agreement shall control.

 

(f)Unless otherwise
superseded by an underwriting agreement entered into in connection with the underwritten public offering, the obligations of the
Company and Holders under this Subsection ‎0 shall survive the completion of any
offering of Registrable Securities in a registration under this Section ‎0, and
otherwise shall survive the termination of this Agreement.

 

2.9Reports
Under Exchange Act. With a view to making available to the Holders the benefits of SEC Rule 144 and any other rule or regulation
of the SEC that may at any time permit a Holder to sell securities of the Company to the public without registration or pursuant
to a registration on Form S-3, the Company shall make and keep available adequate current public information, as those terms are
understood and defined in SEC Rule 144.

 

2.10Limitations
on Subsequent Registration Rights. From and after the date of this Agreement, the Company shall not, without the prior written
consent of the Holders of a majority of the Registrable Securities then outstanding, enter into any agreement with any holder
or prospective holder of any securities of the Company that (i) would provide to such holder the right to include securities in
any registration on other than either a pro rata basis with respect to the Registrable Securities or on a subordinate basis after
all Holders have had the opportunity to include in the registration and offering all shares of Registrable Securities that they
wish to so include; provided that this limitation shall not apply to any additional Stockholder who becomes a party to
this Agreement pursuant to the terms hereof.

 

2.11Transfer
of Registration Rights. The rights under this Section 2 may be assigned (but only with all related obligations)
by a Holder to a transferee of Registrable Securities that (i) is an Affiliate of a Holder; (ii) is a Holder’s Immediate
Family Member or trust for the benefit of an individual Holder or one or more of such Holder’s Immediate Family Members;
or (iii) after such transfer, holds at least 500,000 shares of Registrable Securities (subject to appropriate adjustment for stock
splits, stock dividends, combinations, and other recapitalizations); provided, however, that (x) the transferee
receives the Registrable Securities in a transfer that complies with the requirements of Section 2.12 and Section 4
hereof, (y) the Company is, within a reasonable time after such transfer, furnished with written notice of the name and address
of such transferee and the Registrable Securities with respect to which such rights are being transferred; and (z) such transferee
agrees in a written instrument delivered to the Company to be bound by and subject to the terms and conditions of this Agreement,
including the provisions of Section 6. For the purposes of determining the number of shares of Registrable Securities held
by a transferee, the holdings of a transferee (1) that is an Affiliate or stockholder of a Holder; (2) who is a Holder’s
Immediate Family Member; or (3) that is a trust for the benefit of an individual Holder or such Holder’s Immediate Family
Member shall be aggregated together and with those of the transferring Holder; provided further that all transferees
who would not qualify individually for assignment of rights shall have a single attorney-in-fact for the purpose of exercising
any rights, receiving notices, or taking any action under this Section 2.

 

    	12

    	 

    

2.12Restrictions
on Transfer. 

 

(a)The Preferred
Stock and the Registrable Securities shall not be sold, pledged, or otherwise transferred, and the Company shall not recognize
and shall issue stop-transfer instructions to its transfer agent with respect to any such sale, pledge, or transfer, except upon
the conditions specified in this Agreement, which conditions are intended to ensure compliance with the provisions of the Securities
Act. A transferring Holder will cause any proposed purchaser, pledgee, or transferee of the Preferred Stock and the Registrable
Securities held by such Holder to agree to take and hold such securities subject to the provisions and upon the conditions specified
in this Agreement.

 

(b)Each certificate
or instrument representing (i) the Preferred Stock, (ii) the Registrable Securities, and (iii) any other securities issued in
respect of the securities referenced in clauses (i) and (ii), upon any stock split, stock dividend, recapitalization, merger,
consolidation, or similar event, shall (unless otherwise permitted by the provisions of Subsection 2.12‎0)
be stamped or otherwise imprinted with a legend substantially in the following form:

 

THE SECURITIES REPRESENTED HEREBY
HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933. SUCH SHARES MAY NOT BE SOLD,
PLEDGED, OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR A VALID EXEMPTION FROM THE REGISTRATION AND PROSPECTUS DELIVERY
REQUIREMENTS OF SAID ACT.

 

THE SECURITIES REPRESENTED HEREBY
MAY BE TRANSFERRED ONLY IN ACCORDANCE WITH THE TERMS OF AN AGREEMENT BETWEEN THE COMPANY AND THE STOCKHOLDER, A COPY OF WHICH
IS ON FILE WITH THE SECRETARY OF THE COMPANY.

 

The Holders consent
to the Company making a notation in its records and giving instructions to any transfer agent of the Restricted Securities in
order to implement the restrictions on transfer set forth in this Subsection ‎0.

 

(c)The holder
of each certificate representing Restricted Securities, by acceptance thereof, agrees to comply in all respects with the provisions
of this Section ‎0. Before any proposed sale, pledge, or transfer of any Restricted
Securities, unless there is in effect a registration statement under the Securities Act covering the proposed transaction, the
Holder thereof shall give notice to the Company of such Holder’s intention to effect such sale, pledge, or transfer. Each
such notice shall describe the manner and circumstances of the proposed sale, pledge, or transfer in sufficient detail and, if
reasonably requested by the Company, shall be accompanied at such Holder’s expense by either (i) a written opinion of legal
counsel who shall, and whose legal opinion shall, be reasonably satisfactory to the Company, addressed to the Company, to the
effect that the proposed transaction may be effected without registration under the Securities Act; (ii) a “no action”
letter from the SEC to the effect that the proposed sale, pledge, or transfer of such Restricted Securities without registration
will not result in a recommendation by the staff of the SEC that action be taken with respect thereto; or (iii) any other evidence
reasonably satisfactory to counsel to the Company to the effect that the proposed sale, pledge, or transfer of the Restricted
Securities may be effected without registration under the Securities Act, whereupon the Holder of such Restricted Securities shall
be entitled to sell, pledge, or transfer such Restricted Securities in accordance with the terms of the notice given by the Holder
to the Company. The Company will not require such a legal opinion or “no action” letter in any transaction in which
such Holder distributes Restricted Securities to an Affiliate of such Holder for no consideration; provided that each transferee
agrees in writing to be subject to the terms of this Subsection ‎0. Each certificate
or instrument evidencing the Restricted Securities transferred as above provided shall bear, except if such transfer is made pursuant
to SEC Rule 144, the appropriate restrictive legend set forth in Subsection 2.12‎0,
except that such certificate shall not bear such restrictive legend if, in the opinion of counsel for such Holder and the Company,
such legend is not required in order to establish compliance with any provisions of the Securities Act. The obligations set forth
in this Subsection 2.12 are in addition to any other restrictions on transfer set forth in this Agreement.

 

    	13

    	 

    

2.13Termination
of Registration Rights. The right of any Holder
to request registration or inclusion of Registrable Securities in any registration pursuant to Subsection ‎0
or Subsection ‎0 shall terminate upon the earliest to occur of:

 

(a)the closing
of a Deemed Liquidation Event, as such term is defined in the Company’s Certificate of Incorporation;

 

(b)such time as
Rule 144 or another similar exemption under the Securities Act is available for the sale of all of such Holder’s
shares without limitation during a three-month period without registration; and

 

(c)the fifth (5th)
anniversary of the Company’s first Qualified Public Offering after the date hereof.

 

2.14Aggregation
of Stock. All shares of Registrable Securities held or acquired by Affiliates shall be aggregated together for the purpose
of determining the availability of any rights under this Agreement and such Affiliated persons may apportion such rights as among
themselves in any manner they deem appropriate. 

 

3.Voting
Provisions.

 

3.1Vote
to Increase Authorized Common Stock. Each Stockholder agrees
to vote or cause to be voted all Shares owned by such Stockholder, or over which such Stockholder has voting control, from time
to time and at all times, in whatever manner as shall be necessary to increase the number of authorized shares of Common Stock
from time to time to ensure that there will be sufficient shares of Common Stock available for conversion of all of the shares
of Preferred Stock outstanding at any given time.

 

3.2Restrictions
on Sales of Control of the Company. No Stockholder shall
be a party to any transaction or series of related transactions in which a Person, or a group of related Persons, acquires from
stockholders of the Company shares representing more than fifty percent (50%) of the outstanding voting power of the Company (a
“Stock Sale”) unless all holders of Preferred Stock are allowed to participate in such transaction and the
consideration received pursuant to such transaction is allocated among the parties thereto in the manner specified in the Company’s
Certificate of Incorporation in effect immediately prior to the Stock Sale (as if such transaction were a Deemed Liquidation Event),
unless the holders of a majority of the Preferred Stock elect otherwise by written notice given to the Company at least 10 days
prior to the effective date of any such transaction or series of related transactions.

 

    	14

    	 

    

4.Agreement
Among the Company and the Stockholders.

 

4.1Right
of First Refusal.

 

(a)Grant.
Subject to the terms of Section ‎0 below, each Stockholder hereby unconditionally
and irrevocably grants to the Company a Right of First Refusal to purchase all or any portion of Transfer Stock that such Stockholder
may propose to transfer in a Proposed Transfer, at the same price and on the same terms and conditions as those offered to the
Prospective Transferee.

 

(b)Notice.
Each Stockholder proposing to make a Proposed Transfer must deliver a Proposed Transfer Notice to the Company not later than forty-five
(45) days prior to the consummation of such Proposed Transfer. Such Proposed Transfer Notice shall contain the material terms
and conditions (including price and form of consideration) of the Proposed Transfer and the identity of the Prospective Transferee.
To exercise its Right of First Refusal under this Section 4.1, the Company must deliver a Company Notice to the selling
Stockholder within fifteen (15) days after delivery of the Proposed Transfer Notice.

 

(c)Grant of
Secondary Refusal Right to Stockholders. Subject to the terms of Section ‎0
below, each Stockholder hereby unconditionally and irrevocably grants to the other Stockholders a Secondary Refusal Right to purchase
all or any portion of the Transfer Stock not purchased by the Company pursuant to the Right of First Refusal, as provided in this
Subsection 4.1‎0. If the Company does not intend to exercise its Right of First
Refusal with respect to all Transfer Stock subject to a Proposed Transfer, the Company must deliver a Secondary Notice to the
selling Stockholder and to each other Stockholder to that effect no later than fifteen (15) days after the selling Stockholder
delivers the Proposed Transfer Notice to the Company. To exercise its Secondary Refusal Right, a Stockholder must deliver a Stockholder
Notice to the selling Stockholder and the Company within ten (10) days after the Company’s deadline for its delivery of
the Secondary Notice as provided in the preceding sentence.

 

(d)Undersubscription
of Transfer Stock. If options to purchase have been exercised by the Company and the Stockholder with respect to some but
not all of the Transfer Stock by the end of the 10-day period specified in the last sentence of Subsection 4.1‎0)
(the “Stockholder Notice Period”), then the Company shall, immediately after the expiration of the Stockholder
Notice Period, send written notice (the “Company Undersubscription Notice”) to those Stockholders who fully
exercised their Secondary Refusal Right within the Stockholder Notice Period (the “Exercising Stockholders”).
Each Exercising Stockholder shall, subject to the provisions of this Subsection 4.1‎0,
have an additional option to purchase all or any part of the balance of any such remaining unsubscribed shares of Transfer Stock
on the terms and conditions set forth in the Proposed Transfer Notice. To exercise such option, an Exercising Stockholder must
deliver an Undersubscription Notice to the selling Stockholder and the Company within ten (10) days after the expiration of the
Stockholder Notice Period. In the event there are two or more such Exercising Stockholders that choose to exercise the last-mentioned
option for a total number of remaining shares in excess of the number available, the remaining shares available for purchase under
this Subsection 4.1‎0 shall be allocated to such Exercising Stockholders pro rata
based on the number of shares of Transfer Stock each such Exercising Stockholder has elected to purchase pursuant to the Secondary
Refusal Right (without giving effect to any shares of Transfer Stock that any such Exercising Stockholder has elected to purchase
pursuant to the Company Undersubscription Notice). If the options to purchase the remaining shares are exercised in full by the
Exercising Stockholders, the Company shall immediately notify all of the Exercising Stockholders and the selling Stockholder of
that fact.

 

    	15

    	 

    

(e)Consideration;
Closing. If the consideration proposed to be paid for the Transfer Stock is in property, services or other non-cash consideration,
the fair market value of the consideration shall be as determined in good faith by the Company’s Board of Directors and
as set forth in the Company Notice. If the Company or any Stockholder cannot for any reason pay for the Transfer Stock in the
same form of non-cash consideration, the Company or such Stockholder may pay the cash value equivalent thereof, as determined
in good faith by the Board of Directors and as set forth in the Company Notice. The closing of the purchase of Transfer Stock
by the Company and the Stockholders shall take place, and all payments from the Company and the Stockholders shall have been delivered
to the selling Stockholder, by the later of (i) the date specified in the Proposed Transfer Notice as the intended date of the
Proposed Transfer and (ii) forty-five (45) days after delivery of the Proposed Transfer Notice.

 

(f)Additional
Compliance. If the Company and the Stockholders have not elected to purchase all the Transfer Stock, the Stockholder proposing
the Proposed Transfer may sell such Transfer Stock to the Prospective Transferee on terms not more advantageous to the Prospective
Transferee than those set forth in the Proposed Transfer Notice. If any Proposed Transfer is not consummated within sixty (60)
days after receipt of the Proposed Transfer Notice by the Company, the Stockholder proposing the Proposed Transfer may not sell
any Transfer Stock unless they first comply in full with each provision of this Section ‎0.
The exercise or election not to exercise any right by any Stockholder hereunder shall not adversely affect its right to participate
in any other sales of Transfer Stock subject to this Subsection 4.1.

 

4.2Effect
of Failure to Comply.

 

(a)Transfer
Void; Equitable Relief. Any Proposed Transfer not made in compliance with the requirements of this Agreement shall be null
and void ab initio, shall not be recorded on the books of the Company or its transfer agent and shall not be recognized by the
Company. Each party hereto acknowledges and agrees that any breach of this Agreement would result in substantial harm to the other
parties hereto for which monetary damages alone could not adequately compensate. Therefore, the parties hereto unconditionally
and irrevocably agree that any non-breaching party hereto shall be entitled to seek protective orders, injunctive relief and other
remedies available at law or in equity (including, without limitation, seeking specific performance or the rescission of purchases,
sales and other transfers of Transfer Stock not made in strict compliance with this Agreement).

 

    	16

    	 

    

(b)Violation
of First Refusal Right. If any Stockholder becomes obligated to sell any Transfer Stock to the Company or any Stockholder
(each, a “Buyer”) under this Agreement and fails to deliver such Transfer Stock in accordance with the terms
of this Agreement, such Buyer may, at its option, in addition to all other remedies it may have, send to such Stockholder the
purchase price for such Transfer Stock as is herein specified and transfer to the name of the Buyer (or request that the Company
effect such transfer in the name of an Stockholder) on the Company’s books the certificate or certificates representing
the Transfer Stock to be sold.

 

4.3Exempt
Transfers.

 

(a)Exempted Transfers.
 Notwithstanding the foregoing or anything to the contrary herein, the provisions of Subsections 4.1 shall not apply:
(a) in the case of a Stockholder that is an entity, upon a transfer by such Stockholder to its stockholders, members, partners
or other equity holders, (b) to a pledge of Transfer Stock that creates a mere security interest in the pledged Transfer Stock,
provided that the pledgee thereof agrees in writing in advance to be bound by and comply with all applicable provisions
of this Agreement to the same extent as if it were the Stockholder making such pledge, or (c) in the case of a Stockholder that
is a natural person, upon a transfer of Transfer Stock by such Stockholder that is made (i) for bona fide estate planning purposes,
either during his or her lifetime or on death by will or intestacy and (ii) to his or her spouse, child (natural or adopted),
or any other direct lineal descendant of such Stockholder (or his or her spouse) (all of the foregoing collectively referred to
as “family members”), or any other person approved by the Board of Directors of the Company, or any custodian or trustee
of any trust, partnership or limited liability company for the benefit of, or the ownership interests of which are owned wholly
by, such Stockholder or their respective family members; provided that in the case of clause(s) (a) or (c), the Stockholder
shall deliver prior written notice to the other Stockholder of such pledge, gift or transfer and such shares of Transfer Stock
shall at all times remain subject to the terms and restrictions set forth in this Agreement and such transferee shall, as a condition
to such issuance, deliver a counterpart signature page to this Agreement as confirmation that such transferee shall be bound by
all the terms and conditions of this Agreement as a Stockholder, as applicable (but only with respect to the securities so transferred
to the transferee), including the obligations of a Stockholder with respect to Proposed Transfers of such Transfer Stock pursuant
to Section ‎0.

 

(b)Exempted Offerings.
Notwithstanding the foregoing or anything to the contrary herein, the provisions of Section 4 shall not apply to the sale
of any Transfer Stock (a) to the public in an offering pursuant to an effective registration statement under the Securities Act
of 1933, as amended (a “Public Offering”) or (b) pursuant to a Deemed Liquidation Event (as defined in the
Company’s Certificate of Incorporation in effect immediately prior to such transaction).

 

4.4Prohibited
Transfers. Notwithstanding the
foregoing, no Stockholder shall transfer any Transfer Stock (a) unless such transfer has been approved by the Company’s
Board of Directors, (b) to any entity which, in the determination of the Company’s Board of Directors, directly or indirectly
competes with the Company or (c) to any customer, distributor or supplier of the Company, if the Company’s Board of Directors
should determine that such transfer would result in such customer, distributor or supplier receiving information that would place
the Company at a competitive disadvantage with respect to such customer, distributor or supplier.

 

    	17

    	 

    

4.5Termination
of Transfer Rights and Restrictions. The provisions of
this Section 4 shall automatically terminate upon the earlier of (a) immediately prior to the consummation of a Qualified
Public Offering and (b) the consummation of a Deemed Liquidation Event (as defined in the Company’s Certificate of Incorporation
in effect immediately prior to such transaction).

 

5.Legends. In addition to the
legend set forth in Section 2.12, each certificate representing shares of Transfer Stock held by the Stockholders or issued
to any permitted transferee in connection with a transfer permitted by Section 4 hereof shall be endorsed with the following
legends:

 

THE
SALE, PLEDGE, HYPOTHECATION OR TRANSFER OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE IS SUBJECT TO, AND IN CERTAIN CASES
PROHIBITED BY, THE TERMS AND CONDITIONS OF A CERTAIN STOCKHOLDERS AGREEMENT BETWEEN THE STOCKHOLDER, THE CORPORATION AND CERTAIN
OTHER HOLDERS OF STOCK OF THE CORPORATION. COPIES OF SUCH AGREEMENT MAY BE OBTAINED UPON WRITTEN REQUEST TO THE SECRETARY OF THE
CORPORATION. by accepting any interest in such Shares the person accepting such interest shall be deemed to agree to and shall
become bound by all the provisions of that STOCKHOLDERS Agreement, including certain restrictions on transfer and ownership set
forth therein.

 

Each Stockholder agrees that the Company
may instruct its transfer agent to impose transfer restrictions on the shares represented by certificates bearing the legend referred
to in this Section 5 above to enforce the provisions of this Agreement, and the Company agrees to promptly do so. The legend
shall be removed upon termination of this Agreement at the request of the holder.

 

6.Lock-Up.

 

6.1Agreement
to Lock-Up. Each Stockholder hereby agrees that it will not, without the prior written consent of the managing underwriter,
during the period commencing on the date of the final prospectus relating to the Company’s first Qualified Public Offering
after the date hereof and ending on the date specified by the Company and the managing underwriter (such period not to exceed
180 days), or such other period as may be requested by the Company or an underwriter to accommodate regulatory restrictions on
(1) the publication or other distribution of research reports and (2) analyst recommendations and opinions, including,
but not limited to, the restrictions contained in FINRA Rule 2711(f)(4) or NYSE Rule 472(f)(4), or any successor provisions
or amendments thereto), (a) lend, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase
any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly
or indirectly, any shares of Capital Stock held immediately prior to the effectiveness of the registration statement for the Qualified
Public Offering or (b) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the
economic consequences of ownership of the Capital Stock, whether any such transaction described in clause (a) or (b) above
is to be settled by delivery of Capital Stock or other securities, in cash or otherwise. The foregoing provisions of this Section
6 shall not apply to the sale of any shares to an underwriter pursuant to an underwriting agreement, or the transfer of any
shares to any trust for the direct or indirect benefit of the Stockholder or the immediate family of the Stockholder, provided
that the trustee of the trust agrees to be bound in writing by the restrictions set forth herein, and provided further
that any such transfer shall not involve a disposition for value, and shall only be applicable to the Stockholders if all
officers, directors and holders of more than ten percent (10%) of the outstanding Common Stock (after giving effect to the conversion
into Common Stock of all outstanding Preferred Stock) enter into similar agreements. The underwriters in connection with the Qualified
Public Offering are intended third-party beneficiaries of this Section 6 and shall have the right, power and authority
to enforce the provisions hereof as though they were a party hereto. Each Stockholder further agrees to execute such agreements
as may be reasonably requested by the underwriters in the Qualified Public Offering that are consistent with this Section 6
or that are necessary to give further effect thereto.

 

    	18

    	 

    

6.2Stop
Transfer Instructions. In order to enforce the foregoing covenant, the Company may impose stop-transfer instructions with
respect to the shares of Capital Stock of each Stockholder (and transferees and assignees thereof) until the end of such restricted
period.

 

7.Additional
Covenants.

 

7.1Insurance.
The Company shall use its commercially reasonable efforts to obtain, within ninety (90) days of the date hereof, from financially
sound and reputable insurers Directors and Officers liability insurance and term “key-person” insurance on Jim New,
each in an amount and on terms and conditions satisfactory to the Board of Directors, and will use commercially reasonable efforts
to cause such insurance policies to be maintained until such time as the Board of Directors determines that such insurance should
be discontinued. The key-person policy shall name the Company as loss payee, and neither policy shall be cancelable by the Company
without prior approval by the Board of Directors.

 

8.Miscellaneous.

 

8.1Transfers. Each transferee or
assignee of any Capital Stock subject to this Agreement shall continue to be subject to the terms hereof, and, as a condition
precedent to the Company’s recognizing such transfer, each transferee or assignee shall agree in writing to be subject to
each of the terms of this Agreement by executing and delivering a counterpart signature page to this Agreement. Upon the execution
and delivery of such counterpart signature page by any transferee, such transferee shall be deemed to be a party hereto as if
such transferee were the transferor and such transferee’s signature appeared on the signature pages of this Agreement and
shall be deemed to be Stockholder. The Company shall not permit the transfer of the Capital Stock subject to this Agreement on
its books or issue a new certificate representing any such Capital Stock unless and until such transferee shall have complied
with the terms of this Subsection 8.1. Each certificate representing Capital Stock subject to this Agreement if issued
on or after the date of this Agreement shall be endorsed by the Company with the legend set forth in Section 5.

 

    	19

    	 

    

8.2Successors
and Assigns. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors
and assigns of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the
parties hereto or their respective successors and assigns any rights, remedies, obligations, or liabilities under or by reason
of this Agreement, except as expressly provided in this Agreement.

 

8.3Governing
Law. This Agreement shall be governed by the internal law of the State of Delaware, regardless of the laws that might otherwise
govern under applicable principles of conflicts of law.

 

8.4Counterparts.
This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together
shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf) or
other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid
and effective for all purposes.

 

8.5Titles
and Subtitles. The titles and subtitles used in this Agreement are for convenience only and are not to be considered in construing
or interpreting this Agreement.

 

8.6Notices.
All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively
given upon the earlier of actual receipt or: (i) personal delivery to the party to be notified; (ii) when sent, if sent by electronic
mail or facsimile during the recipient’s normal business hours, and if not sent during normal business hours, then on the
recipient’s next business day; (iii) five (5) days after having been sent by registered or certified mail, return receipt
requested, postage prepaid; or (iv) one (1) business day after the business day of deposit with a nationally recognized overnight
courier, freight prepaid, specifying next-day delivery, with written verification of receipt. All communications shall be sent
to the respective parties at their addresses as set forth on Schedule A hereto, or to the principal office of the Company and
to the attention of the Chief Executive Officer, in the case of the Company, or to such email address, facsimile number, or address
as subsequently modified by written notice given in accordance with this Subsection ‎0.
If notice is given to the Company, a copy shall also be sent to Laura Vaughn, Bilzin Sumberg Baena Price & Axelrod LLP, 1450
Brickell Avenue, 23rd Floor, Miami, FL 33131.

 

8.7Amendments
and Waivers. This Agreement may be amended, modified or terminated and the observance of any term hereof may be waived (either
generally or in a particular instance and either retroactively or prospectively) only by a written instrument executed by (a)
the Company and (b) the holders of a majority of the shares of Common Stock issued or issuable upon conversion of the then outstanding
shares of Preferred Stock held by the Stockholders (voting as a single class and on an as-converted basis; provided, that,
Section 2 of this Agreement may be amended and the observance of any term of Section 2 may be waived (either generally
or in a particular instance, and either retroactively or prospectively) only with the written consent of the Company and the holders
of a majority of the Registrable Securities then outstanding; provided that the Company may in its sole discretion waive
compliance with Subsection ‎0 (and the Company’s failure to object promptly
in writing after notification of a proposed assignment allegedly in violation of Subsection ‎0
shall be deemed to be a waiver). Any amendment, modification, termination or waiver so effected shall be binding upon the
Company, the Stockholders and all of their respective successors and permitted assigns whether or not such party, assignee or
other shareholder entered into or approved such amendment, modification, termination or waiver. Notwithstanding the foregoing,
this Agreement may not be amended, modified or terminated and the observance of any term hereunder may not be waived with respect
to any Stockholder without the written consent of such Stockholder unless such amendment, modification, termination or waiver
applies to all Stockholder in the same fashion. The Company shall give prompt written notice of any amendment, modification or
termination hereof or waiver hereunder to any party hereto that did not consent in writing to such amendment, modification, termination
or waiver. No waivers of or exceptions to any term, condition or provision of this Agreement, in any one or more instances, shall
be deemed to be, or construed as, a further or continuing waiver of any such term, condition or provision.

 

    	20

    	 

    

8.8Severability.
In case any one or more of the provisions contained in this Agreement is for any reason held to be invalid, illegal or unenforceable
in any respect, such invalidity, illegality, or unenforceability shall not affect any other provision of this Agreement, and such
invalid, illegal, or unenforceable provision shall be reformed and construed so that it will be valid, legal, and enforceable
to the maximum extent permitted by law.

 

8.9Aggregation
of Stock. All shares of Registrable Securities held or acquired by Affiliates shall be aggregated together for the purpose
of determining the availability of any rights under this Agreement and such Affiliated persons may apportion such rights as among
themselves in any manner they deem appropriate.

 

8.10Additional
Stockholders. Notwithstanding anything to the contrary contained herein, if the Company issues additional shares of the Company’s
Preferred Stock after the date hereof, any purchaser of such shares of Preferred Stock may become a party to this Agreement by
executing and delivering an additional counterpart signature page to this Agreement, and thereafter shall be deemed a “Stockholder”
for all purposes hereunder. No action or consent by the Stockholders shall be required for such joinder to this Agreement by such
additional Stockholder, so long as such additional Stockholder has agreed in writing to be bound by all of the obligations as
an “Stockholder” hereunder.

 

8.11Entire
Agreement. This Agreement (including any Schedules and Exhibits hereto) constitutes the full and entire understanding and
agreement among the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the
subject matter hereof existing between the parties is expressly canceled.

 

8.12Dispute
Resolution. The parties (a) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of Delaware
and to the jurisdiction of the United States District Court for the District of Delaware for the purpose of any suit, action or
other proceeding arising out of or based upon this Agreement, (b) agree not to commence any suit, action or other proceeding arising
out of or based upon this Agreement except in the state courts of Delaware or the United States District Court for the
District of Delaware, and (c) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such
suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its
property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum,
that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced
in or by such court.

 

    	21

    	 

    

Waiver
of Jury Trial: EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR
ARISING OUT OF THIS AGREEMENT,, THE SECURITIES OR THE SUBJECT MATTER HEREOF OR THEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO
BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION,
INCLUDING, WITHOUT LIMITATION, CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON
LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE
SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH
ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL
COUNSEL.

 

8.13Delays
or Omissions. No delay or omission to exercise any right, power, or remedy accruing to any party under this Agreement, upon
any breach or default of any other party under this Agreement, shall impair any such right, power, or remedy of such nonbreaching
or nondefaulting party, nor shall it be construed to be a waiver of or acquiescence to any such breach or default, or to any similar
breach or default thereafter occurring, nor shall any waiver of any single breach or default be deemed a waiver of any other breach
or default theretofore or thereafter occurring. All remedies, whether under this Agreement or by law or otherwise afforded to
any party, shall be cumulative and not alternative.

 

[Remainder of Page Intentionally Left Blank]

 

 

 

 

 

 

    	22

    	 

    

 

 

IN WITNESS WHEREOF,
the parties have executed this Agreement as of the date first written above.

 

 

NEUROTROPE, INC.

 

By:______________________________________

 

Name: ____________________________________

 

Title:_____________________________________

 

 

 

 

 

 

 

 

Signature
Page to Preferred Stockholders Agreement

 

 

    	 

    	 

    

IN WITNESS WHEREOF,
the parties have executed this Agreement as of the date first written above.

 

 

	Individual
    Stockholder:	 	Entity
    Stockholder:
	__________________________________________________	 	_____________________________________________________
	(Signature)	 	(Name
    of Entity)
	__________________________________________________	 	By:  
         _______________________________________________
	(Print
    Name) 	 	 
	 	 	Name:   _______________________________________________
	 	 	 
	Date:
     _____________________________________________	 	Title:
        _______________________________________________
	 	 	 
	 	 	Date:     _______________________________________________

 

 

PLEASE SIGN EXACTLY AS YOUR NAME APPEARS
ON THE SIGNATURE PAGE OF YOUR SUBSCRIPTION AGREEMENT.

 

 

 

 

 

Signature
Page to Preferred Stockholders Agreement

 

 

    	 

    	 

    

 

 

SCHEDULE A

 

StockholdersEXHIBIT 10.17

 

VOTING AGREEMENT

 

August
23, 2013

 

THIS VOTING AGREEMENT
(this “Agreement”) is made and entered into as of 23, 2013 by and among Neurotrope, Inc., a Nevada corporation
(the “Parent”), Neurosciences Research Ventures, Inc., a West Virginia corporation (“NRV”),
Northlea Partners LLLP ("Abeles"), Jim New ("New"), Dan Alkon ("Alkon"), Hannah
Rose Holdings, LLC ("HRH") and Gottbetter Capital Group, Inc. ("GCG") (each, a "Party"
and together, the "Parties").

 

WHEREAS, Neurotrope BioScience,
Inc. (“Neurotrope”), Neurotrope Acquisition Corp. (“Merger Sub”), a wholly-owned subsidiary
of Parent, and the Parent plan to enter into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”),
pursuant to which Neurotrope would merge with an into Merger Sub (the “Merger”) and become a wholly-owned subsidiary
of Parent.

 

WHEREAS, upon the consummation
of the Merger, NRV, Abeles, New, Alkon, HRH and GCG will hold issued and outstanding shares of the common stock of Parent, par
value $.0001 per share (the "Common Stock") in the numbers set forth opposite each such Party's name on Exhibit
A hereto.

 

WHEREAS, the aforementioned
holders of Common Stock wish to enter into this Agreement with respect to the voting of shares of Common Stock for the election
of the directors of Parent after the Merger.

 

NOW, THEREFORE, in consideration
of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the Parties hereby agree as follows:

 

		1.	From and after the Effective Time (as such term is defined in the Merger Agreement) and until such
time as HRH and GCP cease to own or control shares of Common Stock, each of HRH and GCP shall vote all of the Common Stock that
each beneficially owns (as such term is defined in SEC Rule 13d-3) and shall take all other necessary or desirable actions within
his, her or its control, whether in his, her or its capacity as a stockholder, director, member of a board committee or officer
of the Parent or otherwise, and including attendance at meetings in person or by proxy for purposes of obtaining a quorum and execution
of written consents in lieu of meetings (and shall refrain from taking any action the purpose of which is to frustrate the purposes
of this Section 1), and the Parent shall take all necessary or desirable actions within its control, including calling special
board and stockholder meetings, so that:

 

(i)the
authorized number of directors shall be established and maintained at seven (7), with six (6) directors elected by the holders
of a majority of the issued and outstanding Common Stock, voting as a separate class (each, a "Common Director")
and one (1) director elected by the holders of a majority of the issued and outstanding Series A convertible preferred stock of
Parent (the "Series A Preferred Stock"), voting as a separate class on an as-converted basis;

    	 

    	 

    

 

(ii)the
following five (5) persons shall be nominated and elected to the Board as Common Directors:

 

(A)two (2)
representatives designated by NRV (each, an “NRV Designee”), who initially shall be William S. Singer and Ralph
Bean;

 

(B)two (2)
representatives designated by the holders of a majority in interest of the Shares of Common Stock of Parent held by New and Abeles
(each, an “Abeles Designee”), who initially shall be Dr. John Abeles and Dr. Jim New; and

 

(C)one
(1) independent representative designated by the Board of the Parent (the "Neurotrope Designee"), which designee
has not been determined as of the date of this Agreement; and

 

(iii)subject
to the provisions of applicable law, no NRV Designee, Abeles Designee or Neurotrope Designee shall be removed from the Board unless
such removal is requested in writing by the party that designated such designee.

 

		2.	Each of NRV, Abeles, New and Alkon shall vote all of the Common Stock that each beneficially owns
(as such term is defined in SEC Rule 13d-3) in favor of electing as a Common Director after the Effective Time one independent
representative designated by HRH (the "HRH Designee") as soon as practicable after such representative has been
identified by HRH. For the avoidance of doubt, NRV, Abeles, New and Alkon agree to vote their Common Stock in favor of the election
of the HRH Designee only at the time of such individual's initial appointment to the Parent's Board, and nothing herein shall obligate
NRV, Abeles, New or Alkon to vote in favor of the election of any other individual as an HRH Designee or in favor of the continuing
service of the HRH Designee once elected to the Board.

 

This Agreement may be
executed in two or more counterparts and by facsimile, each of which shall be deemed an original, but all of which together shall
constitute one and the same instrument.

 

[Signature pages follow]

    	2

    	 

    

IN WITNESS WHEREOF,
the parties hereto have executed this Voting Agreement on the day and year first above written.

 

NEUROTROPE, INC.

 

 

By:  /s/ Ronald A. Warren                 

Name: Ronald A. Warren

Title: President

 

    	 

    	 

    

IN WITNESS WHEREOF,
the parties hereto have executed this Voting Agreement on the day and year first above written.

 

NEUROSCIENCES RESEARCH VENTURES, INC.

 

 

By:  /s/ William S. Singer                    

Name: William S. Singer

Title: Director

 

 

 

 

    	[Signature Page to Voting Agreement]

    	 

    

IN WITNESS WHEREOF,
the parties hereto have executed this Voting Agreement on the day and year first above written.

 

 

NORTHLEA PARTNERS LLLP

 

 

By:  /s/ John Abeles                       

Name: John Abeles

Title: Manager of General Partner

 

    	[Signature Page to Voting Agreement]

    	 

    

IN WITNESS WHEREOF,
the parties hereto have executed this Voting Agreement on the day and year first above written.

 

 

JIM NEW

 

 

/s/ Jim New                                      

 

 

 

 

    	[Signature Page to Voting Agreement]

    	 

    

IN WITNESS WHEREOF,
the parties hereto have executed this Voting Agreement on the day and year first above written.

 

 

DAN ALKON

 

 

/s/ Dan
Alkon                                      

 

    	[Signature Page to Voting Agreement]

    	 

    

IN WITNESS WHEREOF,
the parties hereto have executed this Voting Agreement on the day and year first above written.

 

 

 

HANNAH
ROSE HOLDINGS, LLC

 

 

By:  /s/ Matthew Rosenblum               

Name: Matthew Rosenblum

Title: CEO

 

 

    	[Signature Page to Voting Agreement]

    	 

    

IN WITNESS WHEREOF,
the parties hereto have executed this Voting Agreement on the day and year first above written.

 

 

 

GOTTBETTER
CAPITAL GRoup, Inc.

 

 

By:  /s/ Adam S. Gottbetter                        

Name: Adam S. Gottbetter

Title: President

 

 

    	[Signature Page to Voting Agreement]

    	 

    

EXHIBIT
A

 

	Stockholder	Common Stock Held at Closing of Merger
	Neurosciences Research Ventures, Inc.	9,025,000
	Northlea Partners LLLP	5,187,000
	Jim New	3,838,000
	Dan Alkon	950,000
	Hannah Rose Holdings, LLC	2,014,424
	Gottbetter Capital Group, Inc.	488,079
	TOTAL	21,502,503

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00221-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00221-of-00352.parquet"}]]